Enbrel Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Funding
• Alerts
• Clinical Trials

Tolerance to Islet Allotransplants in Diabetes
Conditions: Diabetes Mellitus Type 2 - Insulin-Treated Interventions: Biological: ToleraCell-001; Biological: ToleraCell-002; Drug: DFI-105; Drug: Etanercept; Drug: Tocilizumab; Drug: Sirolimus Sponsors: Diabetes Free, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 7, 2023 Category: Research Source Type: clinical trials

Study of the Efficacy and Safety of Etanercept Treatment in Patients With SAPHO Syndrome
Condition:   SAPHO Syndrome Interventions:   Drug: Etanercept;   Drug: Placebo Sponsors:   National Institute of Geriatrics, Rheumatology and Rehabilitation, Poland;   Medical Research Agency, Poland Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 25, 2023 Category: Research Source Type: clinical trials

RENAL: TNF-alpha Inhibitor for Improving Renal Dysfunction and Primary Graft Dysfunction After Lung Transplant
Condition:   Lung Transplant; Complications Intervention:   Drug: Etanercept Injection [Enbrel] Sponsor:   Northwestern University Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 18, 2023 Category: Research Source Type: clinical trials